Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
cOR (95%CI) | P | aOR(95%CI) | P | |
Gender | ||||
 M²¹±ô±ð | REF | Ìý | REF | Ìý |
 F±ð³¾²¹±ô±ð | 1.07 (0.98–1.17) | 0.111 | 1.22 (1.10–1.28) |  &±ô³Ù; 0.001 |
Age | ||||
 18–59 | REF | Ìý | REF | Ìý |
 60 and above | 0.62 (0.47–0.80) |  &±ô³Ù; 0.001 | 0.56 (0.41–0.76) |  &±ô³Ù; 0.001 |
Region | ||||
 C±ð²Ô³Ù°ù²¹±ô | REF | Ìý | REF | Ìý |
 N´Ç°ù³Ù³ó | 0.84 (0.75–0.95) | 0.004 | 0.95 (0.84–1.08) | 0.419 |
 E²¹²õ³Ù | 0.95 (0.76–1.19) | 0.667 | 0.96 (0.76–1.22) | 0.740 |
â€Çȴdzܳٳó | 0.75 (0.64–0.86) |  &±ô³Ù; 0.001 | 0.77 (0.66–0.90) | 0.001 |
 W±ð²õ³Ù | 1.05 (0.93–1.19) | 0.41 | 0.98 (0.86–1.12) | 0.783 |
Education level | ||||
 Primary school and below | REF | Ìý | REF | Ìý |
 Junior high school | 1.19 (0.76–1.85) | 0.451 | 0.97 (0.61–1.61) | 0.992 |
 Senior high school | 1.40 (0.92–2.11) | 0.113 | 1.31 (0.83–2.05) | 0.244 |
 University or college | 1.16 (0.78–1.72) | 0.469 | 1.25 (0.81–1.94) | 0.313 |
 Graduate degree | 1.25 (0.83–1.87) | 0.292 | 1.38 (0.88–2.18) | 0.164 |
Student status | ||||
 N´Ç | REF | Ìý | REF | Ìý |
 Y±ð²õ | 0.73 (0.67–0.79) |  &±ô³Ù; 0.001 | 0.85 (0.75–0.95) | 0.006 |
Monthly income (CNY) | ||||
 &±ô³Ù; 5000 | REF | Ìý | REF | Ìý |
 5,000–9,999 | 1.17 (1.06–1.30) | 0.002 | 1.03 (0.90–1.17) | 0.699 |
 10,000–29,999 | 1.37 (1.16–1.61) |  &±ô³Ù; 0.001 | 1.29 (1.06–1.56) | 0.012 |
 ≥ 30,000 | 1.53 (1.11–2.10) | 0.009 | 1.47 (1.04–2.09) | 0.028 |
Cohabitation status | ||||
â€Çã±ô´Ç²Ô±ð | REF | Ìý | REF | Ìý |
 C´Ç³ó²¹²ú¾±³Ù²¹³Ù¾±´Ç²Ô | 0.9 (0.77–1.05) | 0.197 | 1.12 (0.94–1.33) | 0.192 |
Chronic disease | ||||
 N´Ç | REF | Ìý | REF | Ìý |
 Y±ð²õ | 1.21 (1.06–1.39) | 0.006 | 1.05 (0.90–1.22) | 0.572 |
Covid-19 infection status | ||||
 U²Ô¾±²Ô´Ú±ð³¦³Ù±ð»å | REF | Ìý | REF | Ìý |
 During infection | 1.81 (1.46–2.24) |  &±ô³Ù; 0.001 | 1.47 (1.16–1.85) | 0.001 |
 R±ð³¦´Ç±¹±ð°ù±ð»å | 1.22 (1.09–1.37) | 0.001 | 1.17 (1.03–1.33) | 0.013 |
Depressive symptoms | ||||
 M¾±²Ô¾±³¾²¹±ô | REF | Ìý | REF | Ìý |
 M¾±±ô»å | 1.46 (1.33–1.60) |  &±ô³Ù; 0.001 | 1.14 (1.02–1.27) | 0.024 |
 M´Ç»å±ð°ù²¹³Ù±ð | 1.93 (1.70–2.19) |  &±ô³Ù; 0.001 | 1.34 (1.14–1.57) |  &±ô³Ù; 0.001 |
â€Çȱ𱹱ð°ù±ð | 2.36 (2.08–2.69) |  &±ô³Ù; 0.001 | 1.38 (1.11–1.70) | 0.003 |
Anxiety symptoms | ||||
 M¾±²Ô¾±³¾²¹±ô | REF | Ìý | REF | Ìý |
 M¾±±ô»å | 1.56 (1.42–1.71) |  &±ô³Ù; 0.001 | 0.99 (0.88–1.12) | 0.865 |
 M´Ç»å±ð°ù²¹³Ù±ð | 1.99 (1.73–2.28) |  &±ô³Ù; 0.001 | 0.99 (0.81–1.21) | 0.953 |
â€Çȱ𱹱ð°ù±ð | 1.94 (1.60–2.35) |  &±ô³Ù; 0.001 | 1.01 (0.77–1.33) | 0.952 |
PTSD symptoms | ||||
 N´Ç | REF | Ìý | REF | Ìý |
 Y±ð²õ | 1.56 (1.44–1.69) |  &±ô³Ù; 0.001 | 1.16 (1.05–1.29) | 0.003 |
Have received other vaccines in the past five years | ||||
 N´Ç | REF | Ìý | REF | Ìý |
 Y±ð²õ | 0.96 (0.88–1.06) | 0.413 | 0.97 (0.88–1.07) | 0.575 |
Have experienced adverse reactions after COVID-19 vaccination | ||||
 N´Ç | REF | Ìý | REF | Ìý |
 Y±ð²õ | 1.61 (1.47–1.75) |  &±ô³Ù; 0.001 | 1.49 (1.36–1.63) |  &±ô³Ù; 0.001 |
Social Support, mean ± SD | 0.87 (0.86–0.87) |  &±ô³Ù; 0.001 | 0.87 (0.86–0.88) |  &±ô³Ù; 0.001 |